Published in Gut Liver on December 31, 2007
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension. Clin Mol Hepatol (2014) 0.86
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis? Clin Mol Hepatol (2012) 0.76
Life-threatening bleeding from peristomal varices after cystoprostatectomy: multimodal approach in a cirrhotic, encephalopathic patient with severe portal hypertension. Case Rep Urol (2015) 0.75
β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis. World J Gastroenterol (2015) 0.75
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med (1989) 2.29
Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology (2006) 1.95
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol (2006) 1.90
Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol (2003) 1.55
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology (2004) 1.47
Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation. Am J Gastroenterol (2000) 1.47
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol (2003) 1.07
Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J Gastroenterol Hepatol (2006) 1.05
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol (2005) 1.03
Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol (2005) 0.99
Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther (1990) 0.94
Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis. Korean J Intern Med (2004) 0.92
Racial differences in beta-adrenoceptor-mediated responsiveness. J Cardiovasc Pharmacol (1995) 0.86
Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial. Gastrointest Endosc (2000) 0.86
Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. J Hepatol (2002) 0.86
[Assessment and current treatment of portal hypertension]. Korean J Hepatol (2005) 0.85
[Pharmacological therapy of portal hypertension--focused on Korean data]. Korean J Gastroenterol (2005) 0.79
[Interequipment variability of Doppler ultrasonographic indices in patients with liver cirrhosis]. Korean J Hepatol (2006) 0.79
Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res (2010) 2.99
Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest Endosc (2007) 2.36
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology (2014) 2.14
Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology (2006) 1.95
An adequate level of training for technical competence in screening and diagnostic colonoscopy: a prospective multicenter evaluation of the learning curve. Gastrointest Endosc (2008) 1.89
Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A (2006) 1.70
[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. Korean J Hepatol (2008) 1.70
EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc (2007) 1.59
A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int (2013) 1.57
DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer (2010) 1.55
Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol (2008) 1.53
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol (2009) 1.48
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J Neurosci (2010) 1.47
Catheter-free method is sufficient for preparation for transnasal endoscopy: randomized controlled trial. Dig Endosc (2013) 1.42
Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density. Clin Chem Lab Med (2014) 1.40
Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol (2013) 1.35
Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion (2011) 1.35
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol (2008) 1.26
Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. Proc Natl Acad Sci U S A (2007) 1.25
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology (2012) 1.23
Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease. J Clin Neurol (2011) 1.21
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer. PLoS One (2011) 1.19
Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc (2013) 1.18
Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol (2010) 1.18
[Review of 209 cases of foreign bodies in the upper gastrointestinal tract and clinical factors for successful endoscopic removal]. Korean J Gastroenterol (2004) 1.16
Dynamic regulation of replication independent deposition of histone H3 in fission yeast. Nucleic Acids Res (2005) 1.16
Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J Biol Chem (2004) 1.15
Genome-wide mapping of NBS-LRR genes and their association with disease resistance in soybean. BMC Plant Biol (2012) 1.13
SUMO modification is involved in the maintenance of heterochromatin stability in fission yeast. Mol Cell (2005) 1.13
Neuron-like differentiation of bone marrow-derived mesenchymal stem cells. Yonsei Med J (2011) 1.13
Colorectal Neoplasm in Asymptomatic Average-risk Koreans: The KASID Prospective Multicenter Colonoscopy Survey. Gut Liver (2009) 1.12
A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection. J Korean Med Sci (2007) 1.12
The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. J Nucl Med (2009) 1.11
Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int (2007) 1.11
RNA-Seq analysis of a soybean near-isogenic line carrying bacterial leaf pustule-resistant and -susceptible alleles. DNA Res (2011) 1.10
Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res Rev (2009) 1.10
H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers. Vet Microbiol (2006) 1.10
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol (2005) 1.10
Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology (2009) 1.10
The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc (2005) 1.09
[A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma]. Korean J Gastroenterol (2009) 1.08
Clinical findings of multiple pregnancy with a complete hydatidiform mole and coexisting fetus. J Ultrasound Med (2010) 1.07
Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord (2007) 1.07
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol (2003) 1.07
Job stress and cardiovascular risk factors in male workers. Prev Med (2005) 1.07
The lipoxygenase gene family: a genomic fossil of shared polyploidy between Glycine max and Medicago truncatula. BMC Plant Biol (2008) 1.06
Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol (2009) 1.06
Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc (2006) 1.06
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics (2008) 1.05
Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol (2011) 1.05
Occupations and Parkinson's disease: a multi-center case-control study in South Korea. Neurotoxicology (2005) 1.05
Clinical significance of small colorectal adenoma less than 10 mm: the KASID study. Hepatogastroenterology (2007) 1.05
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol (2009) 1.04
Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord (2009) 1.03
Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol (2009) 1.03
Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol (2015) 1.02
The prevalence of and risk factors for Barrett's esophagus in a Korean population: A nationwide multicenter prospective study. J Clin Gastroenterol (2009) 1.02
Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant (2008) 1.02
T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol (2010) 1.01
Prehospital notification from the emergency medical service reduces the transfer and intra-hospital processing times for acute stroke patients. J Clin Neurol (2010) 1.01
[Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension]. Korean J Gastroenterol (2009) 1.00
Clinical outcomes and risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage. Clin Endosc (2011) 1.00
[Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis]. Korean J Lab Med (2009) 0.99